Table 1.

Cell cycle regulators or oncogenes

GeneNuc IDaMax fold changebTime (h)
37-kDa leucine-rich repeat (LRR) protein U32907 ∼−4.624
Absent in melanoma 1 (AIM1) AI800499 −7.420
Activator of S-phase kinase AB028069 ∼9.218
Acute myeloid leukemia (AML1) M83215 ∼−618
Aryl hydrocarbon receptor L19872 514
AXL receptor tyrosine kinase M76125 −4.824
Baculoviral IAP repeat-containing 5 (survivin) U75285 ∼−10.54
BRCA1-associated protein 1 AF045581 ∼21.424
BRCA2 region, mRNA sequence CG018 U50527 ∼6.28
BTG family, member 3 D64110 3.924
Butyrate response factor 2 (epidermal growth factor response factor 2) U07802 −3.720
cdc25 S78187 −4.616
cdc2-related protein kinase mRNA M68520 ∼2448
CDC6 (cell division cycle 6,Saccharomyces cerevisiae) homolog U77949 ∼5.920
Cdc6-related protein (HsCDC6) U77949 ∼5.920
Cell division cycle 27 AA166687 ∼3.110
Cell growth regulatory with ring finger domain U66469 5.416
c-fos K00650 ∼44.80.5
Chediak-Higashi syndrome 1 U67615 −5.54
c-kit X06182 ∼−3.248
Coagulation factor II (thrombin) receptor M62424 −4.524
Cyclin A1 U66838 6.320
Cyclin B M25753 ∼−15.41
Cyclin D3 M92287 4.224
Cyclin E2 AF091433 6.220
Cyclin G1 X77794 −3.448
Cyclin T2 AF048731 ∼−4.34
Cyclin-dependent kinase inhibitor 1B (p27, Kip1) AI304854 −78
Cyclin-selective ubiquitin carrier protein U73379 ∼−14.516
Deleted in liver cancer 1 (dlc1) AF035119 −4.724
Diphtheria toxin receptor M60278 ∼23.214
Discs, large (Drosophila) homolog 1 U13896 ∼5.718
E2F transcription factor 5, p130-binding U31556 ∼13.724
E2F-5 U31556 3.524
EphB2 AF025304 4.448
Epithelial membrane protein 1 Y07909 −5.214
ets variant gene 1 U17163 ∼−5.06
Ets2 repressor factor U15655 5.714
Exostoses (multiple) 1 S79639 −7.148
Fatty acid-binding protein 3, muscle and heart AI041520 ∼−4.618
FBJ murine osteosarcoma viral oncogene homolog B L49169 4.110
Fibroblast growth factor 7 (keratinocyte growth factor) M60828 ∼−9.748
Fibroblast growth factor receptor 3 M64347 ∼9.120
Four and a half LIM domains 2 U29332 −5.424
Gonadotropin-releasing hormone 1 X01059 ∼−6.46
Growth arrest and DNA damage-inducible protein (gadd45) M60974 −3.36
Growth arrest-specific 1 L13698 −3.86
highly expressed in cancer, rich in leucine heptad repeats AF017790 −3.320
homeo box A9 U41813 ∼−7.04
IGF-II mRNA-binding protein 3 U97188 −3.714
Interferon regulatory factor 4 U52682 ∼3.88
Kinesin-like 1 U37426 −5.110
Loss of heterozygosity, 11, chromosomal region 2, gene A AI632589 ∼−19.048
MAD (mothers against decapentaplegic, Drosophila) homolog 3 U68019 −4.212
Mad4 homolog AF040963 ∼−12.348
Matrix metalloproteinase 11 (stromelysin 3) X17610 ∼−37.648
MAX-binding protein X96401 −4.610
MAX protein AI693307 ∼10.08
Meis1 (mouse) homolog U85707 −9.148
Melanoma antigen, family A, 2 L18920 ∼−10.41
Menage a trois 1 (CAK assembly factor) X87843 ∼−5.04
Neuropilin 1 AF016050 ∼−9.218
Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) X61498 ∼9.424
Oncogene Ret/Ptc, fusion activatedHG4679– HT5104∼10.148
Oncogene TC21 AI365215 −3.748
p53 activated fragment 1 (WAF1) U03106 −4.448
Peripheral myelin protein 22 D11428 −414
Phorbol-12-myristate-13-acetate-induced protein 1 D90070 17.210
  • a Nuc ID, nucleotide sequence identification or sequence accession number.

  • b Maximum (Max) fold change. A ∼ symbol in front of a fold change value indicates that the transcript was scored as absent in either the baseline or experimental sample and that the fold change was then calculated using the background noise value as the intensity for that comparison. The complete data set with difference calls can be accessed athttp://www.molbio.princeton.edu/labs/shenk/browneetal2001/.